News & Views

From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.

Showing 107 articles

Clear all Filters

A Black man and a Caucasian woman sit at the table with two cups of tea, going through a budget sheet with a pencil, looking concerned

24.10.2022

Let us know how we can help you during the cost-of-living crisis

We want to hear from you about how the cost-of-living crisis is affecting you day-to-day, and any impact ...

22.09.2022

Clinical guidelines for overweight and obesity in England updated

We welcome the latest NICE guidelines for obesity in England recommending healthcare professionals show g...

30.08.2022

Our new Prime Minister must take diabetes seriously

Why it is vital that our government commits to improving diabetes care, and how you can help us influence...

02.08.2022

New Continuous Glucose Monitor available on prescription today

We welcome the addition of a new CGM device to promote greater choice for people with diabetes.

14.06.2022

Government Food Strategy lacks the substance and commitments needed to...

Why we think the Government's new Food Strategy falls short of ambitions to reduce rising levels of obesi...

14.06.2022

50% more children being treated for type 2 diabetes

Our analysis has revealed that the number of children receiving treatment for type 2 diabetes in Paediatr...

10.06.2022

Diabetes UK Cymru calls for access to diabetes psychology across Wales

To mark Diabetes Week (13th to 19th June), Diabetes UK Cymru is launching a campaign to highlight the ine...

10.06.2022

Diabetes doctor Fiona Campbell awarded OBE for services to children an...

Leading diabetes consultant Dr Fiona Campbell has been awarded an OBE for her work in helping to improve ...

16.05.2022

The government mustn't delay action on restrictions to junk food adver...

Jack Doughty, Senior Policy Officer at Diabetes UK, reacts to the government’s announcement that it is de...

05.04.2022

Requirement for calorie labelling in large food establishments comes i...

We welcome the new regulations on calorie labelling on menus that will help people make healthier choices...

23.03.2022

Our reaction to the Spring Statement

Yesterday's Spring Statement from the Chancellor was a missed opportunity to address the rising cost of l...

24.02.2022

Living with Covid: our reaction to the UK Government’s plan

Following the publication of the UK Government’s ‘Living With Covid’ plan, and with the majority of Covid...

A time lapse photo taken from above of people walking on a city street

21.02.2022

We’re calling on the government to fight ethnic health inequality

Last week, the NHS Race and Health Observatory, a body of experts working to fight ethnic health inequali...

03.02.2022

Our response to government's Levelling Up White Paper

Yesterday, the UK Government published the Levelling Up White Paper; a document setting out their plans t...

19.11.2021

Share your thoughts: Integrated Care Systems tackling obesity in England

The All-Party Parliamentary Group (APPG) on Obesity are currently gathering evidence for an inquiry into ...

18.11.2021

Dapagliflozin (Forxiga) is no longer to be used for type 1 diabetes

AstraZeneca has announced that the medication Dapagliflozin (Forxiga) will no longer be licensed for use ...